MedPath

ERYC DELAYED-RELEASE CAPSULES

ERYC DELAYED-RELEASE CAPSULES

Discontinued
DIN Number

00607142

Drug Class

Human

Market Date

Dec 31, 1983

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00607142
AIG Number0105708003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01FA01 ERYTHROMYCIN
Product Specifications
Dosage FormCapsule (Enteric-Coated)
Route of AdministrationOral
AHFS Classification08:12.12.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

ERYTHROMYCINActive
Strength: 250 MG
Monograph: ERYTHROMYCIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.